KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pacira BioSciences (PCRX) Goodwill (2016 - 2025)

Pacira BioSciences (PCRX) has 11 years of Goodwill data on record, last reported at $163.2 million in Q4 2023.

  • For Q4 2023, Goodwill changed 0.0% year-over-year to $163.2 million; the TTM value through Dec 2023 reached $163.2 million, changed 0.0%, while the annual FY2023 figure was $163.2 million, 0.0% changed from the prior year.
  • Goodwill reached $163.2 million in Q4 2023 per PCRX's latest filing, roughly flat from $163.2 million in the prior quarter.
  • Across five years, Goodwill topped out at $163.2 million in Q4 2022 and bottomed at $62.0 million in Q1 2019.
  • Average Goodwill over 5 years is $127.2 million, with a median of $145.2 million recorded in 2021.
  • Peak YoY movement for Goodwill: skyrocketed 45.86% in 2021, then changed 0.0% in 2023.
  • A 5-year view of Goodwill shows it stood at $62.0 million in 2019, then soared by 60.56% to $99.5 million in 2020, then skyrocketed by 45.86% to $145.2 million in 2021, then rose by 12.43% to $163.2 million in 2022, then changed by 0.0% to $163.2 million in 2023.
  • Per Business Quant database, its latest 3 readings for Goodwill were $163.2 million in Q4 2023, $163.2 million in Q4 2022, and $157.4 million in Q3 2022.